Catatonic Symptoms Successfully Treated with Olanzapine in an Adolescent with Schizophrenia

Abrams R , Taylor MA : Catatonia: A prospective clinical study. Arch Gen Psychiatry, 33:579–581, 1976.

Babington PW , Spiegel DR : Treatment of catatonia with olanzapine and amantadine. Psychosomatics, 48:534–536, 2007.

Beach SR , Gomez-Bernal F , Huffman JC , Fricchione GL : Alternative treatment strategies for catatonia: A systematic review. Gen Hosp Psychiatry, 48:1–19, 2017.

Bush G , Fink M , Petrides G , Dowling F , Francis A : Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand, 93:129–136, 1996.

Cassidy EM , O'Brien M , Osman MF , Finucane J , O'Keane V : Lethal catatonia responding to high-dose olanzapine therapy. J Psychopharmacol, 15:302–304, 2001.

Cohen D , Flament M , Dubos PF , Basquin M : Case series: Catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry, 38:1040–1046, 1999.

Cohen D , Nicolas JD , Flament MF , Périsse D , Dubos PF , Bonnot O , Speranza M , Graindorge C , Tordjman S , Mazet P : Clinical relevance of chronic catatonic schizophrenia in children and adolescents: Evidence from a prospective naturalistic study. Schizophr Res, 76:301–308, 2005.

Consoli A , Benmiloud M , Wachtel L , Dhossche D , Cohen D , Bonnot O : Electroconvulsive therapy in adolescents with the catatonia syndrome: Efficacy and ethics. J ECT, 26:259–265, 2010.

Daniels J : Catatonia: Clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci, 21:371–380, 2009.

Delbello MP , Foster KD , Strakowski SM : Case report: Treatment of catatonia in an adolescent male. J Adolesc Heal, 27:69–71, 2000.

Ghaziuddin N , Hendriks M , Patel P , Wachtel LE , Dhossche DM : Neuroleptic malignant syndrome/malignant catatonia in child psychiatry: Literature review and a case series. J Child Adolesc Psychopharmacol, 27:359–365, 2017.

Guzman CS , Myung VHM , Wang YP : Treatment of periodic catatonia with atypical antipsychotic, olanzapine. Psychiatry Clin Neurosci, 62:482–482, 2008.

Hawkins JM , Archer KJ , Strakowski SM , Keck PE : Somatic treatment of catatonia. Int J Psychiatry Med, 25:345–369, 1995.

Matsui-Sakata A , Ohtani H , Sawada Y : Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release. Drug Metab Pharmacokinet, 20:187–199, 2005.

Philbrick KL , Rummans TA : Malignant catatonia. J Neuropsychiatry Clin Neurosci, 6:1–13, 1994.

Pommepuy N , Januel D : Catatonia: Resurgence of a concept. A review of the international literature. Encephale, 28:481–492, 2002.

Raffin M , Zugaj-Bensaou L , Bodeau N , Milhiet V , Laurent C , Cohen D , Consoli A : Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry, 24:441–449, 2015.

Rasmussen SA , Mazurek MF , Rosebush PI : Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry, 6:391, 2016.

Rosebush PI , Mazurek MF : Catatonia and its treatment. Schizophr Bull, 36:239–242, 2010.

Seeman P , Tallerico T : Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry, 3:123–134, 1998.

Tan QR , Wang W , Wang HH , Zhang RG , Guo L , Zhang YH : Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: A case report. Clin Neuropharmacol, 29:154–156, 2006.

Ungvari GS , Chiu HFK , Chow LY , Lau BST , Tang WK : Lorazepam for chronic catatonia: A randomized, double-blind, placebo- controlled cross-over study. Psychopharmacology (Berl), 142:393–398, 1999.

Van Den Eede F , Van Hecke J , Van Dalfsen A , Van Den Bossche B , Cosyns P , Sabbe BGC : The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry, 20:422–429, 2005.